Major Depressive Disorder vs. Persistent Depressive Disorder (Dysthymia)
Clinical Health Psychology

Major Depressive Disorder vs. Persistent Depressive Disorder (Dysthymia)

major-depressive-disorder-vs-persistent-depressive-disorder-dysthymia

Mood can be defined as a pervasive, sustained, and longer duration of feeling endured internally. It impacts the overall behaviour of an individual. Mood disorders are also known as affective disorders. One of the most essential features of mood disorders is the change in emotional levels, marked by relative disruption in emotional states.

The distinguishing features are: Mania (excessive excitement leading to manic episodes), hypomania (less excitement than mania but with elevated mood), and depressive episodes (feelings of sadness, hopelessness, unworthiness, etc.). These common psychiatric disorders are widely prevalent in both males and females. Mood disorders impair an individual’s daily functioning, affecting sleep, routine, and physiological health.

The DSM-5 and ICD-11 classify mood disorders into Bipolar disorders (Bipolar I & II, Cyclothymia) and Depressive disorders (Major Depressive Disorder, Persistent Depressive Disorder/Dysthymia). This article aims to explore depression and dysthymia, compare their similarities and differences, and outline their causes, definitions, and diagnostic criteria (Sekhon et al., 2023; American Psychiatric Association, 2013). 

Major Depressive Disorder (MDD)

Mood disorders were previously categorised under depressive disorders, affective disorders, or depressive neuroses. With the publication of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III) by the American Psychiatric Association in 1980, these were grouped under mood disorders. The most severely described depression is known as a Major Depressive Episode.

The DSM-5 criteria describe it as an extremely depressed mood state for at least two weeks. It includes vegetative, cognitive, and physical symptoms. Major depressive episodes are also marked by loss of interest in day-to-day life. One of the central indicators of MDD is vegetative symptoms. Women are diagnosed more often than men, but men are also diagnosed with depression. Depression can co-occur with chronic illness such as diabetes, cancer, and heart disease.

Depression impacts them, and vice versa. The two common types of depression are major depression and persistent depressive disorder, which is also known as dysthymia. According to estimates, in 2019, 280 million people experienced depression. It is estimated that 12 billion productive days are lost every year to depression and anxiety. Major depressive disorder is associated with a high mortality rate, which is caused by suicide. 

Onset

MDD can begin at any age with no specific onset criteria. Its course varies by individual: some experience single episodes with few symptoms, while others face ongoing symptoms. Risk of recurrence is higher in those with a history of severe episodes. Features associated with lower recovery rates include psychotic symptoms, anxiety, and comorbid personality disorders.

Causes and Treatment

Depression has multiple contributing factors. Family studies indicate that individuals with a family history of major depression are more vulnerable. According to Beck, individuals with depression exhibit negative cognitive styles and distortions, aggravating symptom severity. Sleep disruption and altered circadian rhythms are common, leading to hypersomnia or insomnia.

Significant changes occur in neurotransmitter systems, particularly dopamine; stress reduces dopamine secretion, promoting depressive behaviours. Learned helplessness also plays a role, as individuals project internal helplessness onto external situations. Additional contributing factors involve complex alterations in the endocrine, nervous, and neural systems.

Treatment involves psychopharmacology and psychotherapy, with optimal outcomes achieved through a combined approach. Pharmacotherapy includes antidepressants and mood stabilisers. The primary antidepressant classes are SSRIs, Mixed Reuptake Inhibitors, Tricyclic Antidepressants, and Monoamine Oxidase Inhibitors.

  • SSRIs: SSRIs selectively block presynaptic serotonin reuptake, increasing serotonin availability at receptor sites. Common side effects include nausea, diarrhoea, insomnia, sexual dysfunction, and agitation.
  • Monoamine Oxidase Inhibitors (MAOIs): MAOIs work by inhibiting MAO enzymes that break down key mood-regulating neurotransmitters like serotonin and norepinephrine. 
  • Tricyclic Antidepressants: Frequently prescribed before SSRIs, TCAs block neurotransmitter reuptake. Common side effects include blurred vision, dry mouth, urinary retention, and drowsiness.
  • Electroconvulsive Therapy (ECT): Introduced in the 20th century, modern ECT is safer and highly effective for severe cases. Anaesthesia and muscle relaxants are administered before brief electrical currents are applied to induce controlled therapeutic seizures lasting a few minutes.
  • Cognitive Behavioural Therapy: CBT focuses on identifying and restructuring negative thought patterns. Patients learn how distorted cognitions influence mood and behaviour through structured interventions.
  • Interpersonal Psychotherapy: IPT targets interpersonal relationship conflicts across three stages: Negotiation, Impasse, and Resolution (Barlow & Durand, 2015; American Psychiatric Association, 2013; National Institute of Mental Health, 2024; World Health Organisation, n.d.).

Persistent Depressive Disorders (Dysthymia)

Persistent Depressive Disorder is a chronic, debilitating form of depression affecting 3–6% of the general population. Classification has historically been debated between mood and personality disorders. The DSM-5 defines Persistent Depressive Disorder (PDD) as a chronic depressed mood present for most of the day, more days than not, for at least two years (one year in children and adolescents).

Patients experience persistent low-grade symptoms, often leading to behavioural avoidance and withdrawal from daily activities. PDD is frequently underdiagnosed and shows high comorbidity with other psychiatric disorders. Its aetiology involves complex biopsychosocial factors similar to those of MDD.

First introduced in DSM-III (1980) as dysthymic disorder (previously termed neurotic depression), PDD diagnosis requires depressive symptoms persisting for over two years without symptom-free intervals longer than two months. Crucially, a diagnosis of PDD applies only when criteria for major depressive episodes or manic/hypomanic episodes are not met during the initial period.

PDD significantly impairs daily functioning. Comorbid personality disorders increase symptom severity and distress. Individuals with dysthymia face an estimated 71.4% risk of developing major depression, and suicidal ideation and attempts are notably high. The aetiology mirrors major depression, involving circadian rhythm disruptions, sleep disturbances, and serotonin dysregulation. Thyroid dysfunction is also observed in women with dysthymia.

Cornell Dysthymia Rating Scale

Developed in 1993 by Mason and colleagues, the Cornell Dysthymia Rating Scale (CDRS) is a 20-item instrument designed to assess dysthymia presence and severity over a one-week period. Items are scored from 0 to 4 (total score 0–80), with higher scores indicating greater symptom severity. While effective for screening and progress monitoring, the CDRS provides symptom flags rather than formal clinical diagnoses, which require comprehensive evaluation using diagnostic manuals (DSM or ICD).

Treatment

Treatment for dysthymia aligns with major depression management, combining antidepressant medication with psychotherapy (Spanemberg & Juruena, 2004; Melrose, 2017).

Are they similar? 

Although Major Depressive Disorder and Persistent Depressive Disorder share a depressive disorder classification, their clinical profiles differ significantly across DSM diagnostic criteria.

1. Major Depressive Disorder (MDD)

Requires five or more symptoms during a two-week period, with at least one core symptom being depressed mood or loss of interest/pleasure.

Symptoms of MDD

Depressed Mood most for most of the days, Lack of interest or pleasure in most of the activities, weight loss, insomnia and hypersomnia, psychomotor agitation, fatigue, feelings of worthlessness, inability to think or concentrate, recurrent thoughts of death and suicidal ideation.  At least one major depressive episode must occur without being attributable to schizoaffective disorder.

2. Persistent Depressive Disorder or Dysthymia

Requires depressed mood present for most of the day, for more days than not, over at least two years in adults.

Symptoms of PDD

Poor Appetite, Overeating, Insomnia, Hypersomnia, Fatigue and low self-esteem, poor concentration and a feeling of hopelessness.  Symptoms must persist without symptom-free intervals longer than two months throughout the two-year period. Criteria for MDD should be present continuously for 2 years.  No history of manic or hypomanic episodes; presence of mania indicates Bipolar I or II (American Psychiatric Association, 2013).

The difference 

  1. MDD involves discrete episodic presentations, whereas PDD is defined by chronic depressed mood. 
  2. MDD diagnostic criteria require a minimum duration of two weeks, whereas PDD requires at least two years.
  3. MDD symptoms are typically acute and severe, whereas PDD symptoms are less severe but more persistent.
  4. MDD presents with distinct periods of recovery between episodes, whereas PDD lacks symptom-free intervals longer than two months.

Case Snippet

Identify which case represents MDD versus PDD. What screening tools would you utilise to evaluate comorbidity?

  1. A college-going student experiences sadness, loss of interest, fatigue, feelings of hopelessness, and sleep disturbances for three weeks. These symptoms are significantly interfering with day-to-day life. 
  2. An employee experiences low mood, low self-esteem, and hopelessness for three years. Although he goes to work, he frequently feels unhappy and worthless.  

Conclusion

Major Depressive Disorder and Persistent Depressive Disorder are classified under Depressive Disorders within the broader category of Mood Disorders. MDD and PDD differ in duration, course, and symptom severity despite symptom overlap. Clinicians should utilise validated screening tools to avoid misdiagnosis, as over 51% of depressive conditions remain undiagnosed.

References +

    2 Comments

    • […] Major Depressive Disorder is characterised by the feelings of hopelessness, worthlessness, lack of interest in day to day activity, insomnia or hypersomnia, vegetative symptoms etc. The symptoms of major depressive episodes should persist for two weeks, and one of the important symptoms, i.e., lack of interest, should be present. Major Depressive Disorder is categorised under Mood Disorders. The treatment of major depressive disorder involves both psychological, i.e., therapy and psychopharmacological, i.e., prescription of drugs. […]

    • […] Parkinson’s disease where DBS has proven facts which promises in psychiatric conditions like OCD, major depressive disorder and Tourette’s syndrome would be treated (Zrinzo et al., […]

    Leave a Reply

    Your email address will not be published. Required fields are marked *